Related Experiment Video
Updated: Jun 7, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
p53-dependent repression of polo-like kinase-1 (PLK1)
Lynsey McKenzie1, Sharon King, Lynnette Marcar
1Biomedical Research Institute, University of Dundee, Dundee, UK.
Abstract:
PLK1 is a critical mediator of G₂/M cell cycle transition that is inactivated and depleted as part of the DNA damage-induced G₂/M checkpoint. Here we show that downregulation of PLK1 expression occurs through a transcriptional repression mechanism and that p53 is both necessary and sufficient to mediate this effect. Repression of PLK1 by p53 occurs independently of p21 and of arrest at G₁/S where PLK1 levels are normally repressed in a cell cycle-dependent manner through a CDE/CHR element. Chromatin immunoprecipitation analysis indicates that p53 is present on the PLK1 promoter at two distinct sites termed p53RE1 and p53RE2. Recruitment of p53 to p53RE2, but not to p53RE1, is stimulated in response to DNA damage and/or p53 activation and is coincident with repression-associated changes in the chromatin. Downregulation of PLK1 expression by p53 is relieved by the histone deacetylase inhibitor, trichostatin A, and involves recruitment of histone deacetylase to the vicinity of p53RE2, further supporting a transcriptional repression mechanism. Additionally, wild type, but not mutant, p53 represses expression of the PLK1 promoter when fused upstream of a reporter gene. Silencing of PLK1 expression by RNAi interferes with cell cycle progression consistent with a role in the p53-mediated checkpoint. These data establish PLK1 as a direct transcriptional target of p53, independently of p21, that is required for efficient G₂/M arrest.
Insights
The tumor suppressor p53 directly represses Polo-like kinase 1 (PLK1) gene expression. This p53-mediated transcriptional repression of PLK1 is crucial for the DNA damage-induced G₂/M cell cycle arrest.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Biology
Background:
- Polo-like kinase 1 (PLK1) is essential for G₂/M cell cycle transition.
- PLK1 is inactivated and depleted during the DNA damage-induced G₂/M checkpoint.
- The tumor suppressor protein p53 plays a key role in cell cycle control and DNA damage response.
Purpose of the Study:
- To elucidate the mechanism by which PLK1 expression is downregulated in response to DNA damage.
- To determine the role of p53 in the transcriptional repression of PLK1.
- To investigate the requirement of PLK1 for p53-mediated G₂/M cell cycle arrest.
Main Methods:
- Chromatin immunoprecipitation (ChIP) assays to detect p53 binding to the PLK1 promoter.
- Reporter gene assays to assess p53-mediated transcriptional repression of the PLK1 promoter.
- RNA interference (RNAi) to silence PLK1 expression and assess its effect on cell cycle progression.
- Treatment with histone deacetylase inhibitor (trichostatin A) to investigate the role of chromatin modification.
Main Results:
- p53 directly represses PLK1 gene expression through transcriptional mechanisms, independent of p21.
- p53 binds to two specific sites (p53RE1 and p53RE2) on the PLK1 promoter, with binding to p53RE2 enhanced by DNA damage.
- Histone deacetylase recruitment to the PLK1 promoter is involved in p53-mediated repression.
- Silencing PLK1 expression impairs cell cycle progression, confirming its role in the p53-mediated G₂/M checkpoint.
Conclusions:
- PLK1 is a direct transcriptional target of p53.
- p53-mediated repression of PLK1 is a critical mechanism for achieving G₂/M cell cycle arrest following DNA damage.
- These findings identify a novel pathway in the p53-dependent DNA damage response.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Inhibition of CDK Activity

